Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial.

AIMS To identify better cells for the treatment of diabetic critical limb ischemia (CLI) and foot ulcer in a pilot trial. METHODS Under ordinary treatment, the limbs of 41 type 2 diabetic patients with bilateral CLI and foot ulcer were injected intramuscularly with bone marrow mesenchymal stem cells (BMMSCs), bone marrow-derived mononuclear cells (BMMNCs), or normal saline (NS). RESULTS The ulcer healing rate of the BMMSC group was significantly higher than that of BMMNCs at 6 weeks after injection (P=0.022), and reached 100% 4 weeks earlier than BMMNC group. After 24 weeks of follow-up, the improvements in limb perfusion induced by the BMMSCs transplantation were more significant than those by BMMNCs in terms of painless walking time (P=0.040), ankle-brachial index (ABI) (P=0.017), transcutaneous oxygen pressure (TcO(2)) (P=0.001), and magnetic resonance angiography (MRA) analysis (P=0.018). There was no significant difference between the groups in terms of pain relief and amputation and there was no serious adverse events related to both cell injections. CONCLUSIONS BMMSCs therapy may be better tolerated and more effective than BMMNCs for increasing lower limb perfusion and promoting foot ulcer healing in diabetic patients with CLI.

[1]  W. Vaughn,et al.  Mesenchymal Stem Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Canine Chronic Ischemia Model , 2005, Circulation.

[2]  S. Dulchavsky,et al.  Treatment with bone marrow‐derived stromal cells accelerates wound healing in diabetic rats , 2008, International wound journal.

[3]  Guodong Pan,et al.  Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[4]  D. Smith,et al.  Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. , 1999, Diabetes care.

[5]  K. Kangawa,et al.  Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. , 2005, Cardiovascular research.

[6]  Moustapha Hassan,et al.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells , 2004, The Lancet.

[7]  M. Burnett,et al.  Local Delivery of Marrow-Derived Stromal Cells Augments Collateral Perfusion Through Paracrine Mechanisms , 2004, Circulation.

[8]  V. Bertone,et al.  Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[9]  J. Kurtzberg,et al.  Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  Y. Oiso,et al.  Transplantation of Bone Marrow–Derived Mesenchymal Stem Cells Improves Diabetic Polyneuropathy in Rats , 2008, Diabetes.

[11]  Jacques Galipeau,et al.  Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. , 2003, The Annals of thoracic surgery.

[12]  Darwin J. Prockop,et al.  Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta , 1999, Nature Medicine.

[13]  B. Lévy,et al.  Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. , 2004, The American journal of pathology.

[14]  E. Gale,et al.  The market in diabetes , 2006, Diabetologia.

[15]  M. Longaker,et al.  Aging and Diabetes Impair the Neovascular Potential of Adipose-Derived Stromal Cells , 2009, Plastic and reconstructive surgery.

[16]  Xiaobing Fu,et al.  Enhanced wound‐healing quality with bone marrow mesenchymal stem cells autografting after skin injury , 2006, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[17]  A. Boulton,et al.  Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. , 2001, Diabetes care.

[18]  A. Zander,et al.  Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. , 2004, Experimental hematology.

[19]  M. Kassem,et al.  Human mesenchymal stem cells: from basic biology to clinical applications , 2008, Gene Therapy.

[20]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[21]  J. García-Verdugo,et al.  Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction. , 2010, Journal of the American College of Cardiology.

[22]  Paul G Scott,et al.  Mesenchymal Stem Cells Enhance Wound Healing Through Differentiation and Angiogenesis , 2007, Stem cells.

[23]  M. Cavazzana‐Calvo,et al.  Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia , 2008, Modern Pathology.

[24]  S. Kuroda,et al.  Bone marrow stromal cells and bone marrow‐derived mononuclear cells: Which are suitable as cell source of transplantation for mice infarct brain? , 2010, Neuropathology : official journal of the Japanese Society of Neuropathology.

[25]  A. Kosaki,et al.  Implantation of Bone Marrow Mononuclear Cells Into Ischemic Myocardium Enhances Collateral Perfusion and Regional Function via Side Supply of Angioblasts, Angiogenic Ligands, and Cytokines , 2001, Circulation.

[26]  Pascal Desgranges,et al.  Assessment of critical limb ischemia in patients with diabetes: comparison of MR angiography and digital subtraction angiography. , 2005, AJR. American journal of roentgenology.

[27]  A. Leblond,et al.  Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction , 2009 .

[28]  H. Hammes,et al.  Locally applied mononuclear bone marrow cells restore angiogenesis and promote wound healing in a type 2 diabetic patient. , 2005, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[29]  E. Wagner,et al.  The use of automated data to identify complications and comorbidities of diabetes: a validation study. , 1999, Journal of clinical epidemiology.

[30]  Gabriel P Lasala,et al.  Combination Stem Cell Therapy for the Treatment of Severe Limb Ischemia: Safety and Efficacy Analysis , 2010, Angiology.

[31]  K. Shimada,et al.  Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial , 2002, The Lancet.

[32]  R. Drescher,et al.  Standard-protocol moving-table magnetic resonance angiography for planning of interventional procedures in patients with peripheral vascular occlusive disease. , 2006, Clinical imaging.

[33]  Joshua M Hare,et al.  A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. , 2009, Journal of the American College of Cardiology.

[34]  Nerrolyn Ramstrand,et al.  Incidence of Lower-Limb Amputation in the Diabetic and Nondiabetic General Population , 2009, Diabetes Care.

[35]  C. Mcintosh,et al.  Review Paper: Basic Concepts to Novel Therapies: A Review of the Diabetic Foot , 2010, The international journal of lower extremity wounds.

[36]  K. Houkin,et al.  Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat , 2006, Experimental Neurology.